Clinical Trials Browser

Phase 2/3 × Terminated × Tumor-Agnostic × Clear all

NCT05694013 2025-10-22

ORIGAMA

Phase 2/3 Terminated

49 enrolled 14 charts

Neoplasms

NCT02551458 2024-03-07

Esostrate

Phase 2/3 Terminated

Carcinoma, Squamous Cell